SPCK vs. ARKG
SPCK (SPAC and New Issue ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - SPCK is a Actively Managed fund actively managed by Tuttle, while ARKG is a Health & Biotech Equities fund actively managed by ARK. Both are actively managed. Over the past 5 years, SPCK returned -1.39%/yr vs -14.38%/yr for ARKG. Their 0.06 correlation means their historical movements had little consistent relationship. SPCK charges 0.95%/yr vs 0.75%/yr for ARKG.
Performance
SPCK vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPCK achieves a 1.34% return, which is significantly lower than ARKG's 33.10% return.
SPCK
- 1D
- -0.29%
- 1M
- -0.26%
- 6M
- -0.03%
- YTD
- 1.34%
- 1Y
- 3.66%
- 3Y*
- 3.82%
- 5Y*
- -1.39%
- 10Y*
- —
- ALL TIME*
- 1.18%
ARKG
- 1D
- -1.78%
- 1M
- -10.14%
- 6M
- 26.72%
- YTD
- 33.10%
- 1Y
- 63.67%
- 3Y*
- 1.35%
- 5Y*
- -14.38%
- 10Y*
- 8.25%
- ALL TIME*
- 6.19%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $92.48M | $118.08M | $121.77M | |
| $38.34K | $97.37K | $145.22K |
SPCK vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
SPCK SPAC and New Issue ETF | 1.34% | 7.81% | 2.84% | -4.10% | -12.25% | 9.28% | 3.39% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 33.10% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | -0.73% |
Correlation
The correlation between SPCK and ARKG is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (3Y) Balances recent behavior with more history. | -0.01 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.01 |
Correlation (All Time) Calculated using the full available price history since Dec 16, 2020 | 0.06 |
SPCK vs. ARKG - Sectors Allocation Comparison
Sectors
SPCK
ARKG
Financial Services
Healthcare
Consumer Cyclical
-
Basic Materials
-
-
Communication Services
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Financial Services
SPCK
ARKG
Healthcare
SPCK
ARKG
Consumer Cyclical
SPCK
ARKG
-
Basic Materials
SPCK
-
ARKG
-
Communication Services
SPCK
-
ARKG
-
Consumer Defensive
SPCK
-
ARKG
-
Energy
SPCK
-
ARKG
-
Industrials
SPCK
-
ARKG
-
Real Estate
SPCK
-
ARKG
-
Technology
SPCK
-
ARKG
Utilities
SPCK
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPCK vs. ARKG — Risk / Return Rank
SPCK
ARKG
SPCK vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPAC and New Issue ETF (SPCK) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SPCK | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.98 | ||
| Sortino ratioReturn per unit of downside risk | -1.43 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.25 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.11 | 2.26 | -1.15 |
| Martin ratioReturn relative to average drawdown | 2.02 | 5.42 | -3.40 |
Loading charts...
Drawdowns
SPCK vs. ARKG - Drawdown Comparison
The maximum SPCK drawdown since its inception was -28.28%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for SPCK and ARKG.
Loading charts...
Drawdown Indicators
| SPCK | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.28% | -83.59% | +55.31% |
Max Drawdown (1Y)Largest decline over 1 year | -2.58% | -27.51% | +24.93% |
Max Drawdown (3Y)Largest decline over 3 years | -7.72% | -46.45% | +38.73% |
Max Drawdown (5Y)Largest decline over 5 years | -19.89% | -79.26% | +59.37% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -17.09% | -65.50% | +48.41% |
Average DrawdownAverage peak-to-trough decline | -18.79% | -36.27% | +17.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.44% | 11.46% | -10.02% |
Volatility
SPCK vs. ARKG - Volatility Comparison
The current volatility for SPAC and New Issue ETF (SPCK) is 1.81%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 10.47%. This indicates that SPCK experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPCK | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.81% | 10.47% | -8.66% |
Volatility (6M)Calculated over the trailing 6-month period | 4.84% | 31.28% | -26.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 6.13% | 43.11% | -36.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 8.33% | 46.17% | -37.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 9.20% | 41.44% | -32.24% |
SPCK vs. ARKG - Expense Ratio Comparison
SPCK has a 0.95% expense ratio, which is higher than ARKG's 0.75% expense ratio.
Dividends
SPCK vs. ARKG - Dividend Comparison
SPCK's dividend yield for the trailing twelve months is around 16.27%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
SPCK SPAC and New Issue ETF | 16.27% | 16.48% | 0.69% | 2.27% | 0.00% | 1.28% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
SPCK and ARKG have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (10.47%) compared to SPCK (1.81%). In terms of maximum drawdown, SPCK dropped -28.28% vs ARKG's -83.59%.
On 5-year performance, SPCK leads with -1.39% vs -14.38% for ARKG. On fees, ARKG is cheaper at 0.75% per year. On volatility, SPCK has been the lower-risk option at 1.81%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SPCK has performed better with a -1.39% return vs -14.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKG is cheaper with a 0.75% expense ratio, compared with 0.95% for SPCK.
SPCK has the higher dividend yield at 16.27%, compared with 0.00% for ARKG.
SPCK is categorized as Actively Managed, while ARKG is Health & Biotech Equities. They also come from different issuers: Tuttle and ARK. Their fees differ too: 0.95% for SPCK and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.45 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPCK and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer